Webcast Alert: BioMS Medical Corp. Announces Its Biotech/Pharma/Healthcare On-line Forum Webcast
![]()
Edmonton, AB, June 04 -- BioMS Medical Corp. (Toronto:MS.TO) announces the following Webcast:
What: BioMS Medical Corp. Biotech/Pharma/Healthcare On-line Forum
When: June 06, 2007 @ 9:00 AM Eastern
Where: http://www.investorcalendar.com/EventPage.asp?ID=116688
How: Live over the Internet -- Simply log on to the web at the address above.
Contact: Amanda Stadel, (780)413-7152 or astadel@biomsmedical.com
If you are unable to participate during the live webcast, the call will be available for replay at http://www.investorcalendar.com/ClientPage.asp?ID=116688 or http://www.investorcalendar.com/
![]()
This press release may contain forward-looking statements, which reflect the Corporation’s current expectation regarding future events. These forward-looking statements involve risks and uncertainties that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. Such factors include, but are not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment of corporate alliances, the impact of competitive products and pricing, new product development, uncertainties related to the regulatory approval process and other risks detailed from time to time in the Corporation’s ongoing quarterly and annual reporting. Certain of the assumptions made in preparing forward-looking statements include but are not limited to the following: that dirucotide (MBP8298) will continue to demonstrate a satisfactory safety profile in ongoing and future clinical trials; and that BioMS Medical Corp. will complete the respective clinical trials within the timelines communicated in this release. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
![]()
| Ryan Giese VP Corporate Communications Phone: 780-413-7152 rgiese@biomsmedical.com |
Tony Hesby Executive VP Corporate Affairs Phone: 780-413-7152 thesby@biomsmedical.com |
Amanda Stadel Director Investor Relations Phone: 780-413-7152 astadel@biomsmedical.com |
Subscribe via RSS Feed